Meningitis: Vaccination
(asked on 27th January 2015) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will provide an update of his Department's negotiations with Novartis on finding a cost-effective price for the Bexsero vaccine; and if he will make a statement.
This question was answered on 3rd February 2015
The Department is continuing negotiations with the manufacturer to seek supply of the meningococcal B vaccine, Bexsero® at a cost effective price as recommended by the Joint Committee on Vaccination and Immunisation. These negotiations will be completed as soon as practicable.